BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Ullswater Investments//EU Funding Calls//EN
BEGIN:VEVENT
UID:horizon-miss-2027-02-cancer-03@calls.ullswaterinvestments.com
DTSTAMP:20261106T000000Z
DTSTART;VALUE=DATE:20270916
SUMMARY:Deadline: HORIZON-MISS-2027-02-CANCER-03 – Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventio
DESCRIPTION:EU call deadline (check the exact time on the official page). Details and partners: https://calls.ullswaterinvestments.com/call/horizon-miss-2027-02-cancer-03/
URL:https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/HORIZON-MISS-2027-02-CANCER-03
BEGIN:VALARM
TRIGGER:-P14D
ACTION:DISPLAY
DESCRIPTION:Deadline in 14 days
END:VALARM
BEGIN:VALARM
TRIGGER:-P3D
ACTION:DISPLAY
DESCRIPTION:Deadline in 3 days
END:VALARM
END:VEVENT
END:VCALENDAR
